Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Fortress Biotech (FBIO) Interest & Investment Income (2016 - 2025)

Fortress Biotech has reported Interest & Investment Income over the past 13 years, most recently at $637000.0 for Q4 2025.

  • Quarterly results put Interest & Investment Income at $637000.0 for Q4 2025, up 21.1% from a year ago — trailing twelve months through Dec 2025 was $2.5 million (down 7.35% YoY), and the annual figure for FY2025 was $2.5 million, down 7.38%.
  • Interest & Investment Income for Q4 2025 was $637000.0 at Fortress Biotech, down from $736000.0 in the prior quarter.
  • Over the last five years, Interest & Investment Income for FBIO hit a ceiling of $1.0 million in Q1 2023 and a floor of $132000.0 in Q3 2021.
  • Median Interest & Investment Income over the past 5 years was $568000.0 (2023), compared with a mean of $510950.0.
  • Biggest five-year swings in Interest & Investment Income: plummeted 63.8% in 2021 and later skyrocketed 629.58% in 2023.
  • Fortress Biotech's Interest & Investment Income stood at $144000.0 in 2021, then surged by 377.08% to $687000.0 in 2022, then rose by 2.91% to $707000.0 in 2023, then fell by 25.6% to $526000.0 in 2024, then rose by 21.1% to $637000.0 in 2025.
  • The last three reported values for Interest & Investment Income were $637000.0 (Q4 2025), $736000.0 (Q3 2025), and $622000.0 (Q2 2025) per Business Quant data.